Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 136 publications
Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary Angioedema.
Journal: The New England journal of medicine
Published: June 15, 2026
Real-world quality of life in patients with hereditary angioedema receiving lanadelumab or other long-term prophylaxis.
Journal: Allergy and asthma proceedings
Published: March 17, 2026
Correction to: A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly/Biweekly Dosing in Treatment-Experienced Patients and Loading/Weekly Maintenance Dosing in Treatment-Naïve Patients with Primary Immunodeficiency.
Journal: Journal of clinical immunology
Published: February 02, 2026
Donidalorsen for Long-Term Prophylaxis of Hereditary Angioedema Attacks: Results from the OASISplus Open-Label Extension Cohort at Year 1.
Journal: Journal of asthma and allergy
Published: January 21, 2026
The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparities.
Journal: The World Allergy Organization journal
Published: January 14, 2026
Donidalorsen for the Treatment of Hereditary Angioedema: A Review of Clinical Studies.
Journal: Drug design, development and therapy
Published: January 07, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trials.
Journal: The World Allergy Organization journal
Published: December 22, 2025
Donidalorsen for hereditary angioedema: Long-term results from a 4-year, phase 2, open-label extension study.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: December 17, 2025
Real-world treatment patterns and clinical burden of patients with hereditary angioedema treated with long-term prophylaxis.
Journal: Orphanet journal of rare diseases
Published: December 03, 2025
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-S.
Journal: The journal of allergy and clinical immunology. Global
Published: December 01, 2025
Clinical Evaluation of Pharmacokinetics, Efficacy, and Safety of a 10% Immunoglobulin in Primary Immunodeficiency Disease (CARES10 Study).
Journal: Advances in therapy
Published: November 30, 2025
Lanadelumab Use for Hereditary Angioedema Long-Term Prophylaxis Over the Last 7 Years: A Narrative Review of Clinical and Real-World Data.
Journal: Clinical reviews in allergy & immunology
Published: November 05, 2025
Last Updated: 09/26/2026